Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
53 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PHARMA MANAGEMENT CONSULTING from Wavre, company number BE0632870560, closed financial year 2025 with a result of € -16,180 after tax. For that financial year PHARMA MANAGEMENT CONSULTING recorded a gross margin of € -16,083 and equity of € 199,968. Compared with financial year 2024, the result moved from € -18,703 to € -16,180. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 13, 2025.
€ 199,968
▼ 30% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -16,180
▲ 13 % less loss than in 2024
Profit after tax over the fiscal year.
€ 113,548
▼ 60% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 181,368.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 599
▼ 24% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,359
▲ 49% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 937
▼ 2% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -31,852 | € -44,617 | € -17,507 | € -16,083 | ▲ € 1,424 |
| Profit after taxes | € -33,109 | € -45,977 | € -18,703 | € -16,180 | ▲ € 2,523 |
| Equity | € 469,829 | € 364,851 | € 287,148 | € 199,968 | ▼ 30% |
| Total debts | € 14,358 | € 62,333 | € 60,863 | € 77,169 | ▲ 27% |
| Cash | € 463,119 | € 361,068 | € 283,020 | € 113,548 | ▼ 60% |
| Retained profit | € 451,229 | € 346,251 | € 268,548 | € 181,368 | ▼ 32% |
| Dividend | € 0 | € 59,000 | € 59,000 | € 71,000 | ▲ 20% |
| Balance sheet total | € 484,187 | € 427,185 | € 348,012 | € 277,137 | ▼ 20% |
Key figures of PHARMA MANAGEMENT CONSULTING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to PHARMA MANAGEMENT CONSULTING?
What happened at PHARMA MANAGEMENT CONSULTING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 16,180. Source: NBB ↗
- New establishment in Wavre. KBO
- PATRICK QUINTON became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 33,109 loss in 2022 to € 16,180 loss in 2025.
Paid € 461 in corporate taxes since 2022.
Paid out € 189,000 in dividends to the owners in total.
A new publication or filing at PHARMA MANAGEMENT CONSULTING? We notify you, reason included.
Follow PHARMA MANAGEMENT CONSULTINGDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMA MANAGEMENT CONSULTING is PATRICK QUINTON.
Directors
According to the 2025 annual accounts
PATRICK QUINTON
Director
since 2015
Establishments
Establishment units
Physical locations of this company
Avenue Pasteur 6 box H
1300 Wavre
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 53 companies are registered at this address.
All companies at this address →ADMINISTRATIVE AND TECHNICAL ASSISTANCE
€ 154,802 gross margin · 2024
EDITIONS MERCKX UITGEVERIJ
€ -23,529 gross margin · 2024
ONE PARTNER
€ 1.3 million gross margin · 2025
PROGRESS
€ -32,535 gross margin · 2025
VI.PI
€ -32,541 gross margin · 2025
+48 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
INCAPSULA - Incapsula Inc, US
Domain
Domain
parexel.com
Registered
1995-03-02
Registrar
CSC Corporate Domains, Inc.
Expires
2028-04-09
Website info
Features
Security
Network
Details
- Company number
- 0632.870.560
- VAT number
- BE 0632.870.560
- Registered office
- Avenue Pasteur 6 bus H, 1300 Wavre
- Names & denominations
- PHARMA MANAGEMENT CONSULTING
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 June 2015
- Peppol
- Active · Active since 23 Dec 2025
- Contact
- parexel.com
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering